JOWELL SEABORN: Open Payments
NPI 1427165745 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 21 payments from 5 companies in 2025. Trend: 2023 $228 · 2024 $0 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $195 |
| Amgen Inc. | 7 | $164 |
| AstraZeneca Pharmaceuticals LP | 1 | $86 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $21 |
Products named: Ozempic, REPATHA, BREZTRI, Rybelsus, OTEZLA, REXULTI, QULIPTA, Wegovy.
Industry payments across AL — which companies pay providers there.
